Orthopedic shoes Market Size, Share, Competitive Landscape and Trend Analysis Report, by Sole Type, by Consumer, by Application, by End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

Key Market Dynamics

According to orthopedic shoes market opportunity analysis rise in prevalence of foot-related disorders, rise in elderly population, and increase in awareness of foot health are key factors that drive the growth of the orthopedic shoes market. The growing prevalence of foot-related disorders, such as plantar fasciitis, bunions, arthritis, and flat feet, is a key driver for the orthopedic shoes market. As these conditions cause discomfort, pain, and difficulty in walking, individuals increasingly seek footwear that provide enhanced support, cushioning, and alignment. Orthopedic shoes, designed to address biomechanical issues, relieve pressure on specific areas of the foot and improve overall foot health. According to a 2024 article by American Academy of Orthopaedic Surgeons, rheumatoid arthritis affects approximately 1% of the population. In addition, lifestyle factors such as obesity and diabetes contribute to foot complications, further driving the demand for orthopedic footwear. Thus, the growing prevalence of the foot disorders is expected to drive the orthopedic shoes market growth.

According to orthopedic shoes market forecast analysis rise in elderly population and increased awareness of foot health, are significant factors driving the growth of the orthopedic shoes market. As people age, they become more susceptible to foot-related issues such as arthritis, joint pain, and reduced mobility, which increases the demand for specialized footwear that offer enhanced comfort and support. Orthopedic shoes are designed to cater to these needs, providing better arch support, cushioning, and stability, which are essential for preventing falls and alleviating foot pain in seniors. In addition, increased public awareness about the importance of foot health and the role it plays in overall well-being has led to more people, including younger demographics, opting for orthopedic shoes. Rise in awareness, driven by healthcare campaigns and rise in popularity of foot care products, has expanded the market beyond the elderly, as people are more proactive in addressing foot discomfort and preventing long-term issues. Thus, the rise in geriatric population and growing awareness about orthopedic shoes is expected to drive orthopedic shoes market growth.

Growing Prevalence of Arthritis

The growing prevalence of arthritis is a significant driver for the orthopedic shoes market, as it increases the demand for footwear designed to alleviate the pain and discomfort associated with this condition. Arthritis, particularly osteoarthritis and rheumatoid arthritis, can cause inflammation, joint stiffness, and foot deformities, making it difficult for individuals to wear regular shoes. Orthopedic shoes are specifically designed to provide better support, cushioning, and comfort, helping to reduce the pressure on sensitive joints and improve mobility. As the global population ages, the number of arthritis cases is increasing, further fueling the demand for orthopedic footwear. In addition, rise in awareness of foot health and benefits of wearing specialized shoes are encouraging more people with arthritis to seek out these products, driving the growth of orthopedic shoes market size.

Market Segmentation

The orthopedic shoes industry is segmented on the basis of sole type, consumer, application, and end user, and region. By sole type, the market is classified into in flatfoot orthopedic shoes, cavus orthopedic shoes, calcaneal spur orthopedic shoes, varus orthopedic shoes, valgus orthopedic shoes, and others. By consumer, the market is divided into men, women, and kids. By application, the market is divided into injuries, alignment issues, and foot disorders. By end user, the market is divided into orthopedic clinics, hospitals, and rehabilitation centers. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Regional/Country Market Outlook

North America dominated the orthopedic shoes market share in 2023. The region has a significant number of people suffering from conditions such as arthritis, diabetes, plantar fasciitis, and other foot ailments, which increases the demand for orthopedic footwear. These conditions necessitate specialized footwear that offer support, comfort, and cushioning. Consumers in North America typically have higher purchasing power, allowing them to invest in premium orthopedic footwear for better foot care and comfort.

In the Asia-Pacific region, rapid market expansion is anticipated due to rise in foot-related disorders due to lifestyle changes, including a growing diabetic population and increased cases of arthritis. This leads to higher demand for orthopedic footwear to manage these conditions. Similar to North America, the Asia-Pacific region is also experiencing increase in its aging population, particularly in countries such as Japan and China. This demographic shift contributes to greater demand for orthopedic shoes.

• According to the Center of Disease Control and Prevention, the age-adjusted prevalence of diagnosed arthritis in adults age 18 and older was 18.9% in the U.S. in 2022.
• According to the National Library of Medicine, around 25% of diabetic patients in India develop diabetes foot ulcers.
• According to the World Health Organization, there were 215 million elderly population in Europe in 2021, and it is projected to be 247 million by 2030.
• According to a 2023 article by the United Nations Sexual and Reproductive Health Agency, as of 2023, the elderly population in India was about 153 million, and is expected to reach 347 million by 2050.

Industry Trends

• According to a 2023 article by National Library of Medicine, Clubfoot is the most commonly reported congenital defect of the limbs, with a reported incidence rate of approximately 1 case per 1000 live births.
• According to a 2023 article by National Library of Medicine, the incidence rate of planovalgus in adults ranges from 13.6% to 37%.
• According to a 2023 article by Oxford University, mechanical foot pain affects around 20% of the UK population.
• According to the World Health Organization, 1 in 6 people in the world is expected to be aged 60 years or over by 2030

Competitive Landscape

The orthopedic shoes market report summarizes top key players overview as Enovis, LLC, DARCO International, Inc., MEPHISTO S.A.S, Propet US, Inc., Apex Foot Health Industries, LLC, DUNA-Corradini S.p.A, Vionic Group LLC, Chaneco Limited, Orthofeet, Inc., and Piedro. Other players in the orthopedic shoes market are Drewshoe Incorporated, and New Balance Athletics, Inc.

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the orthopedic shoes market analysis from 2024 to 2033 to identify the prevailing orthopedic shoes market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the orthopedic shoes market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global orthopedic shoes market trends, key players, market segments, application areas, and market growth strategies.